Search
for
Sort by
Research 91–120 of 1000+
- Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer
- Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses
- Urological Oncology: Testis Cancer and Advances in Oncological Therapy
- The evolutionary impact of androgen levels on prostate cancer in a multi-scale mathematical model
- Level-1 Data From the REDUCE Study and the PCPT Data
- Diseases of the Canine Prostate Gland
- Testosterone Deficiency is Not Protective Against the Development of Adenocarcinoma of the Prostate in a Type 1 Diabetic Patient
- Simultaneous quantitation of nine hydroxy-androgens and their conjugates in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry
- Provenge is Talk of GU Malignancies Congress
- Pertinence d’une chimioprévention à partir de l’étude PCPT
- Keeping Our Eye on the Ball: The American Society of Preventive Oncology in 2009
- CPC12 Coinheritance of <i>BRCA2</i> and <i>CYLD</i> germline pathogenic variants associated with targetable metastatic malignant cylindroma
- Safety of Alopecia Treatments in Patients with Breast Cancer and High-Risk Women: A Review
- Comparison of Finasteride and Dutasteride on Risk of Prostate Cancer in Patients with Benign Prostatic Hyperplasia: A Pooled Analysis of 15 Real-world Databases
- 5α- Reductase Inhibitors in Prostate Cancer: An Overview
- Hétérogénéité tumorale du cancer de la prostate et infection par le SARS-CoV2 : une relation complexe impliquant les vésicules extracellulaires et le récepteur des androgènes
- The Transcriptional Co-Activator cAMP Response Element-Binding Protein-Binding Protein Is Expressed in Prostate Cancer and Enhances Androgen- and Anti-Androgen-Induced Androgen Receptor Function
- Risk factors for prostate cancer: a case-control study investigating selected key exposures and their interactions with predisposition genes
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
- Early-onset baldness and the risk of aggressive prostate cancer: findings from a case–control study
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Are PSA adjustments necessary for prostate cancer screening in men taking finasteride for hair loss?
- Male Pattern Baldness in Relation to Prostate Cancer–Specific Mortality: A Prospective Analysis in the NHANES I Epidemiologic Follow-up Study
- Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer
- Re: Long-Term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial
- Vitamin D, Lipid Metabolism and Prostate Cancer
- RE: EFFECT OF THE DUAL 5α-REDUCTASE INHIBITOR DUTASTERIDE ON MARKERS OF TUMOR REGRESSION IN PROSTATE CANCER
- Dutasteride: A Review of its Use in the Management of Prostate Disorders
- Association between male pattern baldness and prostate disease: A meta-analysis